News & Analysis on Clinical Trial Services & Contract Research And Development
Hospira, the leading injectable contract manufacturer in the US, is planning to close two manufacturing plants in the US and Canada in order to improve operational efficiencies and remain competitive in the marketplace.
Biofusion has announced the creation of Genophrenix, a new spin-out company that aims to focus on treatments originating from biochemical pathways implicated in a range of neuropsychiatric diseases, including schizophrenia.
Researchers have isolated a protein molecule that may hold the key to learning and memory disorders that have been linked with autism. By isolating this potential drug target, new therapies for diseases in which synapses either fail or proliferate...
If you're a big pharma company, outsourcing the writing of medical publications is not the way to go, according to a report by pharmaceutical business intelligence firm Cutting Edge Information.
Thermo Electron makes available a new datasheet to provide an overview of the capabilities of its Watson Laboratory Information Management System (LIMS), which is designed to support drug metabolism and pharmacokinetic (DMPK) studies in drug discovery...
According to a new report, the adoption of eClinical technologies has been hampered by the ability to take the electronic revolution to the next level, as the adoption of eClinical technologies currently remain confined to localised start-up projects.
Promed is due to start operations at its new research centre in India, New Deli, this month, in a move that will bring the company closer to becoming a global provider of drug development and supply services.
A consortium of US scientists have developed and evaluated a robust new system for analysing how drugs bind to proteins, which could speed up the delivery of potential new drugs and improve existing ones.